Medlab Clinical (Medlab Clinical) EV-to-EBITDA : -1.90 (As of May. 18, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Medlab Clinical EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medlab Clinical's enterprise value is $7.33 Mil. Medlab Clinical's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-3.86 Mil. Therefore, Medlab Clinical's EV-to-EBITDA for today is -1.90.

The historical rank and industry rank for Medlab Clinical's EV-to-EBITDA or its related term are showing as below:

MDBBF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -52.59 Med: -4.59 Max: 0.57
Current: -1.92

During the past 8 years, the highest EV-to-EBITDA of Medlab Clinical was 0.57. The lowest was -52.59. And the median was -4.59.

MDBBF's EV-to-EBITDA is not ranked
in the Biotechnology industry.
Industry Median: 10.35 vs MDBBF: -1.92

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-18), Medlab Clinical's stock price is $15.75. Medlab Clinical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-2.001. Therefore, Medlab Clinical's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Medlab Clinical EV-to-EBITDA Historical Data

The historical data trend for Medlab Clinical's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlab Clinical EV-to-EBITDA Chart

Medlab Clinical Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EV-to-EBITDA

Get a 7-Day Free Trial

-7.98

-2.72

-3.28

-1.60

-2.59

Medlab Clinical Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EV-to-EBITDA	Get a 7-Day Free Trial											-3.28	-	-1.60	-	-2.59

Competitive Comparison of Medlab Clinical's EV-to-EBITDA

For the Biotechnology subindustry, Medlab Clinical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medlab Clinical's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medlab Clinical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Medlab Clinical's EV-to-EBITDA falls into.

Medlab Clinical EV-to-EBITDA Calculation

Medlab Clinical's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	7.325	/	-3.856
	=	-1.90

Medlab Clinical's current Enterprise Value is $7.33 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medlab Clinical's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-3.86 Mil.

Medlab Clinical (OTCPK:MDBBF) EV-to-EBITDA Explanation

Medlab Clinical's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	15.75	/	-2.001
	=	At Loss

Medlab Clinical's share price for today is $15.75.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medlab Clinical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-2.001.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Medlab Clinical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Medlab Clinical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlab Clinical (Medlab Clinical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medlab Clinical Ltd (OTCPK:MDBBF) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

11 Lord Street, Unit 5, Botany, NSW, AUS, 2019

Website

https://www.medlab.co

Medlab Clinical Ltd is a medical research and development company. It is engaged in researching and formulating novel biotherapeutics to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease, pre-diabetes, and obesity. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.